These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28133878)

  • 21. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of adult female acne with a novel weekly oestradiol-loaded peel-off mask: a split-face placebo-controlled study.
    El-Komy MHM; Youssef DKA; Shamma RN; Bedair NI
    Clin Exp Dermatol; 2024 Apr; 49(5):478-483. PubMed ID: 38078373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne.
    Stinco G; Bragadin G; Trotter D; Pillon B; Patrone P
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):320-5. PubMed ID: 17309452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
    Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
    Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris.
    Eichenfield LF; Gold LS; Nahm WK; Cook-Bolden FE; Pariser DM
    J Drugs Dermatol; 2016 Dec; 15(12):1496-15027. PubMed ID: 28095573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of a facial serum and a mask containing salicylic acid and lipohydroxy acid in acne management: A randomized controlled trial.
    Li S; He X; Zhang Z; Zhang XS; Niu YG; Steel A; Wang HT
    J Cosmet Dermatol; 2023 Sep; 22(9):2502-2511. PubMed ID: 36999489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative split-face study of photodynamic therapy with indocyanine green and indole-3-acetic acid for the treatment of acne vulgaris.
    Jang MS; Doh KS; Kang JS; Jeon YS; Suh KS; Kim ST
    Br J Dermatol; 2011 Nov; 165(5):1095-100. PubMed ID: 21692772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isotretinoin 5 mg daily for low-grade adult acne vulgaris--a placebo-controlled, randomized double-blind study.
    Rademaker M; Wishart JM; Birchall NM
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):747-54. PubMed ID: 23617693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, tolerability, impact on quality of life and sebostatic activity of three topical preparations for the treatment of mild to moderate facial acne vulgaris.
    Stinco G; Piccirillo F; Valent F; Errichetti E; DI Meo N; Trevisan G; Patrone P
    G Ital Dermatol Venereol; 2016 Jun; 151(3):230-8. PubMed ID: 25236322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation.
    Alexis A; Del Rosso JQ; Forman S; Martorell A; Browning J; Laquer V; Desai SR; York JP; Chavda R; Dhawan S; Moore AY; Stein-Gold L
    Int J Dermatol; 2024 Jun; 63(6):806-815. PubMed ID: 38685118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
    Leyden JJ; Tanghetti EA; Miller B; Ung M; Berson D; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):12-9. PubMed ID: 12095064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial.
    Woolery-Lloyd H; Baumann L; Ikeno H
    J Cosmet Dermatol; 2010 Mar; 9(1):22-7. PubMed ID: 20367669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D; Arsonnaud S; Soto P
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
    Lucky A; Jorizzo JL; Rodriguez D; Jones TM; Stewart DM; Tschen EH; Kanof NB; Miller BH; Wilson DC; Loven KH
    Cutis; 2001 Oct; 68(4 Suppl):34-40. PubMed ID: 11845946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris.
    Chan H; Chan G; Santos J; Dee K; Co JK
    Int J Dermatol; 2017 Jun; 56(6):686-690. PubMed ID: 28369875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.